Published in Semin Immunopathol on February 26, 2008
Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35
Mediators of ocular angiogenesis. J Genet (2009) 1.17
Modified C-reactive protein might be a target autoantigen of TINU syndrome. Clin J Am Soc Nephrol (2010) 1.16
Resolution, the grail for healthy ocular inflammation. Exp Eye Res (2010) 0.97
Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem (2011) 0.96
Role of ocular complement factor H in a murine model of choroidal neovascularization. Am J Pathol (2010) 0.95
Comparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularization. Mol Vis (2011) 0.87
Complement regulatory protein CD46 protects against choroidal neovascularization in mice. Am J Pathol (2014) 0.83
Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma. Mol Immunol (2011) 0.83
Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem (2011) 0.81
Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU). Mol Immunol (2010) 0.81
Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol Vis Sci (2014) 0.81
Complement expression in the retina is not influenced by short-term pressure elevation. Mol Vis (2014) 0.78
The Complement Regulatory Protein CD46 Deficient Mouse Spontaneously Develops Dry-Type Age-Related Macular Degeneration-Like Phenotype. Am J Pathol (2016) 0.76
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts. BMC Ophthalmol (2016) 0.75
Risk factors of uveitis in ankylosing spondylitis: An observational study. Medicine (Baltimore) (2016) 0.75
Activated complement classical pathway in a murine model of oxygen-induced retinopathy. Int J Ophthalmol (2015) 0.75
Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland. PLoS One (2016) 0.75
Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome. Sci Rep (2015) 0.75
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet (2006) 7.49
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (1984) 4.68
Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res (2001) 4.38
Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol (1991) 4.27
Molecular organization and function of the complement system. Annu Rev Biochem (1988) 3.91
Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A (2006) 3.25
Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep (2006) 2.69
A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res (2000) 2.58
Control of the complement system. Adv Immunol (1996) 2.43
The role of complement in inflammation and phagocytosis. Immunol Today (1991) 2.04
Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol (2007) 2.00
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol (2005) 1.89
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med (1995) 1.74
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A (2007) 1.62
Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol (1993) 1.50
Structure-function relationships of complement receptor type 1. Immunol Rev (2001) 1.47
Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Vis Sci (1991) 1.47
Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J Immunol (1995) 1.45
Differential gene expression in anatomical compartments of the human eye. Genome Biol (2005) 1.44
Immune privilege in the anterior chamber of the eye. Crit Rev Immunol (2002) 1.44
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol (2006) 1.42
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med (2003) 1.38
The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol (2007) 1.37
Decay-accelerating factor and membrane cofactor protein. Curr Top Microbiol Immunol (1990) 1.34
Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol (2002) 1.33
Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest (1985) 1.31
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol (2007) 1.31
Tissue distribution of complement regulatory membrane proteins in rats. Immunology (1994) 1.29
Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol (1997) 1.27
Subretinal neovascularization. Natural history of an experimental model. Arch Ophthalmol (1982) 1.27
Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci (2000) 1.27
Activation and control of the complement system. Essays Biochem (1986) 1.27
Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids. Biochem J (1990) 1.22
Estimation of systemic complement C3 activity in age-related macular degeneration. Arch Ophthalmol (2007) 1.22
Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci (1993) 1.20
Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol (1994) 1.19
Membrane cofactor protein. Curr Top Microbiol Immunol (1992) 1.17
Biological effects of C1 inhibitor. Drug News Perspect (2004) 1.17
T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci (1998) 1.13
Genetic susceptibility to age related macular degeneration. J Med Genet (2000) 1.11
Complement factor H: spatial and temporal expression and localization in the eye. Invest Ophthalmol Vis Sci (2006) 1.10
Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci (1990) 1.10
Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. J Immunol (1997) 1.08
A new model of subretinal neovascularization in the rabbit. Invest Ophthalmol Vis Sci (1995) 1.08
Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci (2000) 1.07
The simple design of complement factor H: Looks can be deceiving. Mol Immunol (2006) 1.07
Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics (1998) 1.07
Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. J Immunol (2000) 1.06
Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Exp Eye Res (2005) 1.03
Alternate and classical pathway components of complement in the normal cornea. Arch Ophthalmol (1980) 1.02
Complement and complement regulatory proteins in human tears. Invest Ophthalmol Vis Sci (1997) 1.02
Decay accelerating factor (CD55). Curr Top Microbiol Immunol (1992) 1.00
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol (2006) 1.00
The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci (2006) 1.00
Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett (2007) 0.97
Role of complement in murine corneal infection caused by Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci (1983) 0.96
Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis. Infect Immun (1984) 0.96
Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver. Clin Immunol (2007) 0.95
Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci (1990) 0.95
Activated complement in inflamed aqueous humor. Invest Ophthalmol Vis Sci (1984) 0.94
Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland. Curr Eye Res (1994) 0.93
Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol (2004) 0.93
Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing. J Immunol (1995) 0.93
Intraocular diseases - anterior uveitis. Chem Immunol Allergy (2007) 0.92
Distribution of hemolytic complement in the normal cornea. Arch Ophthalmol (1981) 0.92
Alternate pathway activation of complement in a Proteus mirabilis ulceration of the cornea. Arch Ophthalmol (1978) 0.91
Membrane inhibitor of reactive lysis. Curr Top Microbiol Immunol (1992) 0.90
Mechanisms of age-related macular degeneration. Ophthalmol Clin North Am (2002) 0.90
Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Cell Immunol (1990) 0.90
Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch Immunol Ther Exp (Warsz) (2004) 0.88
Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1. J Immunol (1994) 0.88
Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor. Invest Ophthalmol Vis Sci (1984) 0.88
Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells. Glycobiology (2002) 0.87
Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularization. FEBS J (2006) 0.87
Anaphylatoxin levels in human aqueous humor. Invest Ophthalmol Vis Sci (1986) 0.83
Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues. Invest Ophthalmol Vis Sci (1999) 0.83
Generation of complement-derived anaphylatoxins in normal human donor corneas. Invest Ophthalmol Vis Sci (1990) 0.82
Hemolytic complement activity in aqueous humor. Arch Ophthalmol (1983) 0.81
Hemolytic complement activity in normal human donor corneas. Arch Ophthalmol (1980) 0.80
[The dynamics of leucocytes and complements in endotoxin induced uveitis]. Nippon Ganka Gakkai Zasshi (1989) 0.80
Generation of complement membrane attack complex in normal human corneas. Invest Ophthalmol Vis Sci (1996) 0.79
Complement deposits on ocular tissues adjacent to sites of inflammation. Curr Eye Res (2007) 0.78
A review of treatments for macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials. Curr Opin Ophthalmol (2004) 0.78
Release of complement regulatory proteins from ocular surface cells in infections. Curr Eye Res (2000) 0.78
Human corneal extract enhances serum complement activity. Invest Ophthalmol Vis Sci (1994) 0.76
The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs. Invest Ophthalmol Vis Sci (1992) 0.76
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol (2005) 1.89
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol (2006) 1.42
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med (2003) 1.38
The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol (2007) 1.37
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol (2007) 1.31
Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice. J Biol Chem (2010) 1.02
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol (2006) 1.00
The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci (2006) 1.00
Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem (2011) 0.96
Role of ocular complement factor H in a murine model of choroidal neovascularization. Am J Pathol (2010) 0.95
Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol (2004) 0.93
Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells. Am J Pathol (2008) 0.90
Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J Biol Chem (2011) 0.85
Alcohol and nicotine consumption exacerbates choroidal neovascularization by modulating the regulation of complement system. FEBS Lett (2008) 0.84
Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPARgamma Agonists, 15-Deoxy-Delta 12, 14-Prostaglandin J(2). PPAR Res (2008) 0.83
Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II. Cell Biol Int (2009) 0.83
Inhibitory role of adiponectin peptide I on rat choroidal neovascularization. Biochim Biophys Acta (2012) 0.83
Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem (2011) 0.81
Crucial role of apoptosis in the resolution of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci (2007) 0.81
Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU). Mol Immunol (2010) 0.81
Complement system and the eye. Adv Exp Med Biol (2006) 0.81
Antigen-specific tolerance inhibits autoimmune uveitis in pre-sensitized animals by deletion and CD4+CD25+ T-regulatory cells. Immunol Cell Biol (2009) 0.80
Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis. J Biol Chem (2009) 0.80
The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cells. Life Sci (2003) 0.79
Complement, innate immunity and ocular disease. Chem Immunol Allergy (2007) 0.78
The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model. Curr Eye Res (2011) 0.77
The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration. Retina (2012) 0.75
Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU). Ocul Immunol Inflamm (2005) 0.75